FdaApplication
NDA 021602
Identifiers
- fda_app_no: NDA021602
Properties
| Property | Value |
|---|---|
| applicant_name | TAKEDA PHARMACEUTICALS USA INC |
| application_type | NDA |
| approval_date | 2003-05-13 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VELCADE | BORTEZOMIB | 3.5MG/VIAL | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
1 product